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Book Reviews
PHYSICIANS' GENRX, 5th Edition. Philip L. Denniston, Jr., Editor-in-Chief.
Riverside, CT, Denniston Publishing, Inc, 1995. 2,271 pp. $77.00.
When data on prescription drugs are required, most people think of the Physicians'
Desk Reference (PDR). In recent years, there has been an alternative source, the
Physicians'GenR,. It, too, is acompendium ofthe standard prescribing information: indi-
cations, contraindications, dosages, side effects, etc. The GenRx is well-organized, listing
brand names, generic names and therapeutic categories in asingle index. References to 24
pages ofcolor photos, on the other hand, are inconveniently listed in a second index with-
out cross-referencing.
A comparison between the GenRx and the PDR reveals marked differences in organi-
zation. The GenRx presents information without the PDR's emphasis on drug manufac-
turer's data. Mostofits datainstead are obtained from U.S. Food andDrugAdministration
sources. The drugs in the GenRx are listed alphabetically by generic name, instead of
reported by manufacturer as in the PDR, thus preventing multiple listings of the same
compound under multiple brand names; specific information for each drug is supplied for
what the editors deem the most representative brand. Another distinction between the two
books is that the GenRx lacks the chemical formulae that are occasionally found in the
PDR.
The major strength of the GenRx, however, is its wealth of pricing data. The cost of
various brands and dosages are listed, along with comparisons between the cost ofa drug
regiment vs. hospitalization costs associated with non-treatment. The index also contains
revealing lists of the top-selling 400 drugs and those brands with sales above $1 billion,
$500 million and $100 million. Individuals who require such cost information will find
the GenRx invaluable in this regard.
But in actuality, the GenRx and PDR more often than not present exactly the same
drug information, especially formajor branded drugs currently under patent. As an exam-
ple, when one looks up Coumadin, Prozac or Retrovir, the data printed are practically
identical in both books. Thus, the grounds forchoosing one overthe other fall on theirrel-
ative strengths; the PDR's design is particularly well-suited for brand name reference, but
if one needs pricing comparisons, the Physicians'GenRx is highly recommended.
Jersey Chen
Medical Student
Yale University School ofMedicine
BIOCHEMISTRY, 4th Edition. By Lubert Stryer. New York, Freeman, 1995. 1064 pp.
$ 69.95.
It is difficult to say too many good things about a textbook as nearly perfect as this
one. In his preface to the first edition, Dr. Stryer mentions the comment of the Chinese
scholar Tai T'ung that "Were I to await perfection, my book would never be finished."
With this in mind, his latest effort is probably as close to being "finished" as possible. It
is hardly surprising that this book is as good as it is, considering the fact that Dr. Stryer
has had three prior editions to practice on, before surpassing himself yet again with this
magnum opus ofbiochemical thought. Ifyou are someone looking for a single volume to
lucidly explain, or perhaps to help you review, all of the field ofbiochemistry, you need
look no further.
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